Alexandria Real Estate Equities | ARE - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Alexandria Real Estate Equities USD 8.42B 596M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
American Homes 4 Rent USD 12.06B 1.9B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Boston Properties USD 11.21B 642M 2026-08
Brandywine Realty USD 507M 217M 2025-12
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Camden Property USD 11.51B 1.28B 2026-06
COPT Defense Properties USD 4.28B 150M 2026-08
Cousins Properties USD 4.93B 1.18B 2026-06
Digital Realty USD 64.23B 1.34B 2026-06
Douglas Emmett USD 2B 425M 2026-08
EastGroup Properties USD 10.89B 937M 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
EPR Properties USD 4.44B 616M 2026-06
Equity Lifestyle Properties USD 12.5B 394M 2026-06
Equity Residential USD 25.45B 3.29B 2026-06
Gilead Sciences USD 168.68B 11.82B 2026-08
Healthpeak Properties Inc USD 11.42B 248M 2026-03
Highwoods Properties USD 3.33B 965M 2026-06
Hudson Pacific Properties USD 1.94B 1.62B 2026-08
Illumina USD 26.71B 8.84B 2026-06
Kilroy Realty USD 4.56B 198M 2026-08
LTC Properties USD 1.67B 299M 2026-08
Medical Properties USD 2.77B 17M 2026-08
National Health Investors USD 3.18B 520M 2026-08
ProLogis USD 126.3B 3.08B 2026-06
Quest Diagnostics USD 23.46B 1.77B 2026-06
Realty Income USD 282.1B 224.33B 2026-08
Rexford Industrial Realty USD 7.56B 213M 2026-06
SL Green Realty USD 3.68B 1.06B 2026-06
STAG Industrial USD 7.28B 383M 2026-06
Terreno Realty USD 5.97B 915M 2026-08
UDR USD 12.56B 408M 2026-08
Vornado Realty USD 7.35B 37M 2026-08
Welltower USD 133.37B 26.85B 2026-08